- recruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
This study is looking at a cream called ruxolitinib for children aged 6 to 11 with a skin condition called nonsegmental vitiligo. Researchers want to see how well it works to reduce white patches and if it's safe to use.
Argentina · Austria · Belgium - active not recruitingPHASE3
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
This study is testing a new medicine called povorcitinib for people with a type of vitiligo called nonsegmental vitiligo. Researchers want to see if it's safe and helps improve the skin patches. It's a Phase 3 trial, meaning it's a later stage of research.
United States · Bulgaria · Canada - authorisedTherapeutic exploratory (Phase II)
A multicenter, randomized, double-blind, placebo-controlled, dose-ranging Phase IIb study to assess the efficacy and safety of GIA632 in adult participants with non-segmental vitiligo followed by an extension period
This study is testing a new medicine, GIA632, for adults with vitiligo. It aims to see how well it helps improve skin colour and if it's safe. Some people will get the new medicine, others will get a dummy medicine.
Germany · Netherlands · France